-
admin
Posts
Saramonic Released WiTalk9 Series to Redefine Wireless Intercom System at IBC 2024
AMSTERDAM, Sept. 14, 2024 /PRNewswire/ — Saramonic, a leading power in audio technology, released its latest wireless intercom headset system, the WiTalk9 Series, at a product...
Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024
Planegg/Martinsried, September 14, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of...
KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program
RIYADH, Saudi Arabia, Sept. 14, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) is redefining patient engagement and care through its...
Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024
Updated data show consistent objective response rate of 40% and manageable safety profile in patients with non-small cell lung cancer harboring epidermal growth factor receptor...
Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
Treatment data were analyzed from 3,276 cases of patients with newly diagnosed EGFR mutant NSCLC from Guardant Health Analyses of patients with non-classical EGFR mutations...
RYBREVANT®▼ (amivantamab) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancer
Post-progression outcomes showed significant and sustained improvement for amivantamab plus chemotherapy versus chemotherapy alone1 BEERSE, BELGIUM , Sept. 14, 2024 (GLOBE NEWSWIRE) — Janssen-Cilag International...
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
NANJING, China, Sept. 14, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets),...
Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)
In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for up to one week...
Chengdu booming as global e-commerce hub
CHENGDU, China, Sept. 14, 2024 /PRNewswire/ — With cross-border trade representing a new direction for e-commerce in recent years, cross-border e-commerce in Chengdu has experienced...
Sunwoda Inside at RE+ 2024: Showcasing Comprehensive Energy Storage Solutions Across the Full Industrial Chain
ANAHEIM, Calif., Sept. 14, 2024 /PRNewswire/ — At RE+ 2024, Sunwoda made a significant impact under the theme “Sunwoda Inside,” underscoring its leadership in providing end-to-end...